Update on human prion disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 6, 2007, Pages 598-609

  Wadsworth, Jonathan D F ^a   Collinge, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Fatal familial insomnia; Gerstmann Str ussler Scheinker disease; Kuru; Prion; Prion disease; Prion protein; Transmissible spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

ISOPROTEIN; PRION PROTEIN;

CLINICAL FEATURE; CLINICAL STUDY; DISEASE TRANSMISSION; HUMAN; IATROGENIC DISEASE; INCUBATION TIME; KURU; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; PHYSICAL CHEMISTRY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; VARIANT CREUTZFELDT JAKOB DISEASE;

ANIMALS; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MODELS, BIOLOGICAL; PRION DISEASES; PRIONS;

BOS; BOVINAE;

EID: 34249984739     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.02.010     Document Type: Review

References (155)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
2. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24 (2001) 519-550
3. Wadsworth J.D., Hill A.F., Beck J.A., and Collinge J. Molecular and clinical classification of human prion disease. Br. Med. Bull. 66 (2003) 241-254
4. Collinge J. Molecular neurology of prion disease. J. Neurol. Neurosurg. Psychiatry 76 (2005) 906-919
5. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
6. Weissmann C. The state of the prion. Nat. Rev., Microbiol. 2 (2004) 861-871
7. Mallucci G., and Collinge J. Rational targeting for prion therapeutics. Nat. Rev., Neurosci. 6 (2005) 23-34
8. Kristiansen M., Messenger M.J., Klohn P.C., Brandner S., Wadsworth J.D., Collinge J., and Tabrizi S.J. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase-activation and apoptosis. J. Biol. Chem. 280 (2005) 38851-38861
9. Telling G.C., Parchi P., DeArmond S.J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., and Prusiner S.B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274 (1996) 2079-2082
10. Collinge J., Sidle K.C.L., Meads J., Ironside J., and Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
11. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sims A.A.F., Trojanowski J.Q., Petersen R.B., and Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39 (1996) 767-778
12. Wadsworth J.D.F., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., and Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1 (1999) 55-59
13. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N., Piccardo P., Poser S., Rojiani A., Streichenberger N., Julien J., Vital C., Ghetti B., Gambetti P., and Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46 (1999) 224-233
14. Gambetti P., Kong Q., Zou W., Parchi P., and Chen S.G. Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66 (2003) 213-239
15. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., Ironside J.W., and Collinge J. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
16. Zanusso G., Farinazzo A., Prelli F., Fiorini M., Gelati M., Ferrari S., Righetti P., Rizzuto N., Frangione B., and Monaco S. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 279 (2004) 38936-38942
17. Lewis V., Hill A.F., Klug G.M., Boyd A., Masters C.L., and Collins S.J. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 65 (2005) 113-118
18. Safar J.G., Geschwind M.D., Deering C., Didorenko S., Sattavat M., Sanchez H., Serban A., Vey M., Baron H., Giles K., Miller B.L., DeArmond S.J., and Prusiner S.B. Diagnosis of human prion disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3501-3506
19. Collinge J., Brown J., Hardy J., Mullan M., Rossor M.N., Baker H., Crow T.J., Lofthouse R., Poulter M., Ridley R., Owen F., Bennett C., Dunn G., Harding A.E., Quinn N., Doshi B., Roberts G.W., Honavar M., Janota I., and Lantos P.L. Inherited prion disease with 144 base pair gene insertion: II. Clinical and pathological features. Brain 115 (1992) 687-710
20. Brown P., Cathala F., Raubertas R.F., Gajdusek D.C., and Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 37 (1987) 895-904
21. Collins S.J., Sanchez-Juan P., Masters C.L., Klug G.M., van Duijn C., Poleggi A., Pocchiari M., Almonti S., Cuadrado-Corrales N., Pedro-Cuesta J., Budka H., Gelpi E., Glatzel M., Tolnay M., Hewer E., Zerr I., Heinemann U., Kretszchmar H.A., Jansen G.H., Olsen E., Mitrova E., Alperovitch A., Brandel J.P., Mackenzie J., Murray K., and Will R.G. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129 (2006) 2278-2287
22. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum. Mol. Genet. 6 (1997) 1699-1705
23. Wadsworth J.D., Joiner S., Linehan J.M., Cooper S., Powell C., Mallinson G., Buckell J., Gowland I., Asante E.A., Budka H., Brandner S., and Collinge J. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 129 (2006) 1557-1569
24. Collinge J., Palmer M.S., and Dryden A.J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337 (1991) 1441-1442
25. Palmer M.S., Dryden A.J., Hughes J.T., and Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 (1991) 340-342
26. Windl O., Dempster M., Estibeiro J.P., Lathe R., De Silva R., Esmonde T., Will R., Springbett A., Campbell T.A., Sidle K.C.L., Palmer M.S., and Collinge J. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum. Genet. 98 (1996) 259-264
27. Lee H.S., Brown P., Cervenáková L., Garruto R.M., Alpers M.P., Gajdusek D.C., and Goldfarb L.G. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J. Infect. Dis. 183 (2001) 192-196
28. Mead S., Stumpf M.P., Whitfield J., Beck J.A., Poulter M., Campbell T., Uphill J., Goldstein D., Alpers M., Fisher E.M., and Collinge J. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300 (2003) 640-643
29. Mead S., Mahal S.P., Beck J., Campbell T., Farrall M., Fisher E., and Collinge J. Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP Exon 1. Am. J. Hum. Genet. 69 (2001) 1225-1235
30. Vollmert C., Windl O., Xiang W., Rosenberger A., Zerr I., Wichmann H.E., Bickeboller H., Illig T., and Kretzschmar H.A. Significant association of a M129V independent polymorphism in the 5′ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J. Med. Genet. 43 (2006) e53
31. Jimi T., Wakayama Y., Shibuya S., Nakata H., Tomaru T., Takahashi Y., Kosaka K., Asano T., and Kato K. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin. Chim. Acta 211 (1992) 37-46
32. Zerr I., Bodemer M., Räcker S., Grosche S., Poser S., Kretzschmar H.A., and Weber T. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 345 (1995) 1609-1610
33. Hsich G., Kenney K., Gibbs Jr. C.J., Lee K.H., and Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335 (1996) 924-930
34. Collinge J. New diagnostic tests for prion diseases. N. Engl. J. Med. 335 (1996) 963-965
35. Otto M., Stein H., Szudra A., Zerr I., Bodemer M., Gefeller O., Poser S., Kretzschmar H.A., Mader M., and Weber T. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J. Neurol. 244 (1997) 566-570
36. Knight R. Creutzfeldt-Jakob disease: a rare cause of dementia in elderly persons. Clin. Infect. Dis. 43 (2006) 340-346
37. Kropp S., Finkenstaedt M., Zerr I., Schroter A., and Poser S. Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease. Nervenarzt 71 (2000) 91-95
38. Matoba M., Tonami H., Miyaji H., Yokota H., and Yamamoto I. Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J. Comput. Assist. Tomogr. 25 (2001) 274-277
39. Shiga Y., Miyazawa K., Sato S., Fukushima R., Shibuya S., Sato Y., Konno H., Doh-ura K., Mugikura S., Tamura H., Higano S., Takahashi S., and Itoyama Y. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 63 (2004) 443-449
40. Young G.S., Geschwind M.D., Fischbein N.J., Martindale J.L., Henry R.G., Liu S., Lu Y., Wong S., Liu H., Miller B.L., and Dillon W.P. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am. J. Neuroradiol. 26 (2005) 1551-1562
41. Tschampa H.J., Zerr I., and Urbach H. Radiological assessment of Creutzfeldt-Jakob disease. Eur. Radiol. (2006) (published online 9 November 2006)
42. Macfarlane R., Wroe S.J., Collinge J., Yousry T.A., and Jäger H.R. A review of the neuroimaging findings in human prion disease. J. Neurol. Neurosurg. Psychiatry (2006) (published online 11 December 2006)
43. Budka H. Neuropathology of prion diseases. Br. Med. Bull. 66 (2003) 121-130
44. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., Jellinger K., Kretzschmar H.A., Lantos P.L., Masullo C., Schlote W., Tateishi J., and Weller R.O. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases). Brain Pathol. 5 (1995) 459-466
45. Bell J.E., Gentleman S.M., Ironside J.W., McCardle L., Lantos P.L., Doey L., Lowe J., Fergusson J., Luthert P., McQuaid S., and Allen I.V. Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol. Appl. Neurobiol. 23 (1997) 26-35
46. Brown P., Rodgers-Johnson P., Cathala F., Gibbs Jr. C.J., and Gajdusek D.C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann. Neurol. 16 (1984) 295-304
47. Gomori A.J., Partnow M.J., Horoupian D.S., and Hirano A. The ataxic form of Creutzfeldt-Jakob disease. Arch. Neurol. 29 (1973) 318-323
48. Mizutani T. Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type. Acta Pathol. Jpn. 31 (1981) 903-922
49. Matsusue E., Kinoshita T., Sugihara S., Fujii S., Ogawa T., and Ohama E. White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am. J. Neuroradiol. 25 (2004) 910-918
50. Salazar A.M., Masters C.L., Gajdusek D.C., and Gibbs Jr. C.J. Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann. Neurol. 14 (1983) 17-26
51. Morita K., Kaiya H., Ikeda T., and Namba M. Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. Arch. Gerontol. Geriatr. 6 (1987) 263-277
52. Collinge J., and Palmer M.S. Prion Diseases (1997), Oxford Univ. Press, Oxford
53. Kovacs G.G., Trabattoni G., Hainfellner J.A., Ironside J.W., Knight R.S., and Budka H. Mutations of the prion protein gene phenotypic spectrum. J. Neurol. 249 (2002) 1567-1582
54. Mead S. Prion disease genetics. Eur. J. Hum. Genet. 14 (2006) 273-281
55. Riek R., Wider G., Billeter M., Hornemann S., Glockshuber R., and Wuthrich K. Prion protein NMR structure and familial human spongiform encephalopathies. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11667-11672
56. Swietnicki W., Petersen R.B., Gambetti P., and Surewicz W.K. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273 (1998) 31048-31052
57. Muramoto T., DeArmond S.J., Scott M., Telling G.C., Cohen F.E., and Prusiner S.B. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix. Nat. Med. 3 (1997) 750-755
58. Hegde R.S., Mastrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., DeArmond S.J., Prusiner S.B., and Lingappa V.R. A transmembrane from of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
59. Collinge J., Poulter M., Davis M.B., Baraitser M., Owen F., Crow T.J., and Harding A.E. Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases. Am. J. Hum. Genet. 49 (1991) 1351-1354
60. Medori R., Tritschler H.J., LeBlanc A., Villare F., Manetto V., Chen H.Y., Xue R., Leal S., Montagna P., Cortelli P., Tinuper P., Avoni P., Mochi M., Baruzzi Q., Hauw J.J., Ott J., Lugaresi E., Autilio-Gambetti L., and Gambetti P. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326 (1992) 444-449
61. Mastrianni J.A., Nixon R., Layzer R., DeArmond S.J., and Prusiner S.B. Fatal sporadic insomnia (FSI): fatal familial insomnia (FFI) phenotype without a mutation of the prion protein (PrP) gene. Neurology 48 (1997) A296
62. Montagna P., Gambetti P., Cortelli P., and Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol. 2 (2003) 167-176
63. Collinge J., Harding A.E., Owen F., Poulter M., Lofthouse R., Boughey A.M., Shah T., and Crow T.J. Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 2 (1989) 15-17
64. Collinge J., Owen F., Poulter M., Leach M., Crow T.J., Rossor M.N., Hardy J., Mullan M.J., Janota I., and Lantos P.L. Prion dementia without characteristic pathology. Lancet 336 (1990) 7-9
65. Mallucci G.R., Campbell T.A., Dickinson A., Beck J., Holt M., Plant G., De Pauw K.W., Hakin R.N., Clarke C.E., Howell S., Davies-Jones G.A.B., Lawden M., Smith C.M.L., Ince P., Ironside J.W., Bridges L.R., Dean A., Weeks I., and Collinge J. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 122 (1999) 1823-1837
66. Mead S., Poulter M., Beck J., Webb T.E., Campbell T.A., Linehan J.M., Desbruslais M., Joiner S., Wadsworth J.D., King A., Lantos P., and Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129 (2006) 2297-2317
67. Collinge J., and Prusiner S.B. Terminology of Prion Disease. In: Prusiner S.B., Collinge J., Powell J., and Anderton B. (Eds). Prion Diseases of Humans and Animals (1992), Ellis Horwood, London 5-12
68. Collinge J. Human Prion Diseases: aetiology and clinical features. In: Growdon J.H., and Rossor M. (Eds). The Dementias, Blue Books of Practical Neurology (1998), Butterworth-Heinemann, Newton, MA 113-148
69. Brown P., Preece M.A., and Will R.G. Friendly fire in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340 (1992) 24-27
70. Brown P., Preece M., Brandel J.P., Sato T., McShane L., Zerr I., Fletcher A., Will R.G., Pocchiari M., Cashman N.R., D'Aignaux J.H., Cervenáková L., Fradkin J., Schonberger L.B., and Collins S.J. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55 (2000) 1075-1081
71. Belay E.D. Transmissible spongiform encephalopathies in humans. Annu. Rev. Microbiol. 53 (1999) 283-314
72. Heath C.A., Barker R.A., Esmonde T.F., Harvey P., Roberts R., Trend P., Head M.W., Smith C., Bell J.E., Ironside J.W., Will R.G., and Knight R.S. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J. Neurol. Neurosurg. Psychiatry 77 (2006) 880-882
73. Lane K.L., Brown P., Howell D.N., Crain B.J., Hulette C.M., Burger P.C., and DeArmond S.J. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 34 (1994) 737-740
74. Alpers M.P. Epidemiology and clinical aspects of kuru. In: Prusiner S.B., and McKinley M.P. (Eds). Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease (1987), Academic Press, San Diego 451-465
75. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D.J., and Alpers M.P. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367 (2006) 2068-2074
76. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., and Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
77. Hill A.F., Desbruslais M., Joiner S., Sidle K.C.L., Gowland I., and Collinge J. The same prion strain causes vCJD and BSE. Nature 389 (1997) 448-450
78. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., and Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 (1997) 498-501
79. Asante E.A., Linehan J.M., Desbruslais M., Joiner S., Gowland I., Wood A., Welch J., Hill A.F., Lloyd S.E., Wadsworth J.D.F., and Collinge J. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21 (2002) 6358-6366
80. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 354 (1999) 317-323
81. Hilton D.A., Ghani A.C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., and Ironside J.W. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203 (2004) 733-739
82. Frosh A., Smith L.C., Jackson C.J., Linehan J.M., Brandner S., Wadsworth J.D., and Collinge J. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 364 (2004) 1260-1262
83. Hilton D.A. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J. Pathol. 208 (2005) 134-141
84. Wadsworth J.D.F., Joiner S., Hill A.F., Campbell T.A., Desbruslais M., Luthert P.J., and Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immuno-blotting assay. Lancet 358 (2001) 171-180
85. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., and Will R.G. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
86. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., and Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
87. Wroe S., Pal S., Siddique D., Hyare H., Macfarlane R., Joiner S., Linehan J.M., Brandner S., Wadsworth J.D., and Collinge J. Clinical presentation and pre-mortem diagnosis of blood transfusion associated variant Creutzfeldt-Jakob Disease. Lancet 368 (2006) 2061-2067
88. Ironside J.W., and Head M.W. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr. Top. Microbiol. Immunol. 284 (2004) 133-159
89. Spencer M.D., Knight R.S., and Will R.G. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324 (2002) 1479-1482
90. Green A.J.E., Thompson E.J., Stewart G.E., Zeidler M., McKenzie J.M., Macleod M.A., Ironside J.W., Will R.G., and Knight R.S.G. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 70 (2001) 744-748
91. Collie D.A., Summers D.M., Sellar R.J., Ironside J.W., Cooper S., Zeidler M., Knight R., and Will R.G. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am. J. Neuroradiol. 24 (2003) 1560-1569
92. Chazot G., Broussolle E., Lapras C.I., Blattler T., Aguzzi A., and Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347 (1996) 1181
93. Zeidler M., Sellar R.J., Collie D.A., Knight R., Stewart G., Macleod M.A., Ironside J.W., Cousens S., Colchester A.C., Hadley D.M., Will R.G., and Colchester A.F. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355 (2000) 1412-1418
94. Siddique D., Kennedy A., Thomas D., Wroe S., Stevens J., Wadsworth J., Brandner S., Linehan J., Joiner S., Jones J., Frosh A., Hill D., Tolley N., Rossor M., and Collinge J. Tonsil biopsy in the investigation of suspected variant Creutzfeldt-Jakob disease-a cohort study of 50 patients. J. Neurol. Sci. 238 Supplement 1 (2005) S1-S570
95. Rossetti A.O., Bogousslavsky J., Glatzel M., and Aguzzi A. Mimicry of variant Creutzfeldt-Jakob disease by sporadic Creutzfeldt-Jakob disease: importance of the pulvinar sign. Arch. Neurol. 61 (2004) 445-446
96. Mihara M., Sugase S., Konaka K., Sugai F., Sato T., Yamamoto Y., Hirota S., Sakai K., and Sakoda S. The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma. J. Neurol. Neurosurg. Psychiatry 76 (2005) 882-884
97. Yoshimura N., and Soma Y. A case of benign intracranial hypertension with bilateral reversible thalamic lesions on magnetic resonance imaging. Rinsho Shinkeigaku. 32 (1992) 327-329
98. Hahn J.S., Sum J.M., and Lee K.P. Unusual MRI findings after status epilepticus due to cat-scratch disease. Pediatr. Neurol. 10 (1994) 255-258
99. Harding B.N., Alsanjari N., Smith S.J., Wiles C.M., Thrush D., Miller D.H., Scaravilli F., and Harding A.E. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J. Neurol. Neurosurg. Psychiatry 58 (1995) 320-325
100. Cusmai R., Bertini E., Di Capua M., Ricci S., Vigevano F., Milani L., and Fariello G. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics 25 (1994) 44-47
101. Hill A.F., and Collinge J. Strain variations and species barriers. Contrib. Microbiol. 7 (2001) 48-57
102. Bruce M.E. TSE strain variation. Br. Med. Bull. 66 (2003) 99-108
103. Bessen R.A., and Marsh R.F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68 (1994) 7859-7868
104. Sc molecules with different conformations. Nat. Med. 4 (1998) 1157-1165
105. Lloyd S.E., Onwuazor O.N., Beck J.A., Mallinson G., Farrall M., Targonski P., Collinge J., and Fisher E.M.C. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6279-6283
106. Lloyd S.E., Linehan J.M., Desbruslais M., Joiner S., Buckell J., Brandner S., Wadsworth J.D., and Collinge J. Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J. Gen. Virol. 85 (2004) 2471-2478
107. Parchi P., Capellari S., Chen S.G., Petersen R.B., Gambetti P., Kopp N., Brown P., Kitamoto T., Tateishi J., Giese A., and Kretzschmar H. Typing prion isoforms. Nature 386 (1997) 232-233
108. Hill A., Joiner S., Beck J., Campbell T.A., Dickinson A., Poulter M., Wadsworth J.D., and Collinge J. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129 (2006) 676-685
109. Piccardo P., Dlouhy S.R., Lievens P.M.J., Young K., Bird T.D., Nochlin D., Dickson D.W., Vinters H.V., Zimmerman T.R., Mackenzie I.R.A., Kish S.J., Ang L.C., De Carli C., Pocchiari M., Brown P., Gibbs C.J., Gajdusek D.C., Bugiani O., Ironside J., Tagliavini F., and Ghetti B. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J. Neuropathol. Exp. Neurol. 57 (1998) 979-988
110. Parchi P., Chen S.G., Brown P., Zou W., Capellari S., Budka H., Hainfellner J., Reyes P.F., Golden G.T., Hauw J.J., Gajdusek D.C., and Gambetti P. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8322-8327
111. Furukawa H., Doh-ura K., Kikuchi H., Tateishi J., and Iwaki T. A comparative study of abnormal prion protein isoforms between Gerstmann-Sträussler-Scheinker syndrome and Creutzfeldt-Jakob disease. J. Neurol. Sci. 158 (1998) 71-75
112. Cardone F., Liu Q.G., Petraroli R., Ladogana A., D'Alessandro M., Arpino C., Di Bari M., Macchi G., and Pocchiari M. Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients. Brain Res. Bull. 49 (1999) 429-433
113. Piccardo P., Liepnieks J.J., William A., Dlouhy S.R., Farlow M.R., Young K., Nochlin D., Bird T.D., Nixon R.R., Ball M.J., DeCarli C., Bugiani O., Tagliavini F., Benson M.D., and Ghetti B. Prion proteins with different conformations accumulate in Geustmann-Straussler-Scheinker disease caused by A117V and F198S mutations. Am. J. Pathol. 158 (2001) 2201-2207
114. Tagliavini F., Lievens P.M.J., Tranchant C., Warter J.M., Mohr M., Giaccone G., Perini F., Rossi G., Salmona M., Piccardo P., Ghetti B., Beavis R.C., Bugiani O., Frangione B., and Prelli F. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J. Biol. Chem. 276 (2001) 6009-6015
115. Gabizon R., Telling G., Meiner Z., Halimi M., Kahana I., and Prusiner S.B. Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat. Med. 2 (1996) 59-64
116. Silvestrini M.C., Cardone F., Maras B., Pucci P., Barra D., Brunori M., and Pocchiari M. Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients. Nat. Med. 3 (1997) 521-525
117. Chen S.G., Parchi P., Brown P., Capellari S., Zou W.Q., Cochran E.J., Vnencak-Jones C.L., Julien J., Vital C., Mikol J., Lugaresi E., Autilio-Gambetti L., and Gambetti P. Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat. Med. 3 (1997) 1009-1015
118. Muramoto T., Tanaka T., Kitamoto N., Sano C., Hayashi Y., Kutomi T., Yutani C., and Kitamoto T. Analyses of Gerstmann-Straussler syndrome with 102Leu219Lys using monoclonal antibodies that specifically detect human prion protein with 219Glu. Neurosci. Lett. 288 (2000) 179-182
119. Zanusso G., Farinazzo A., Fiorini M., Gelati M., Castagna A., Righetti P.G., Rizzuto N., and Monaco S. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. J. Biol. Chem. 276 (2001) 40377-40380
120. Sc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem. 279 (2004) 16797-16804
121. Cali I., Castellani R., Yuan J., Al Shekhlee A., Cohen M.L., Xiao X., Moleres F.J., Parchi P., Zou W.Q., and Gambetti P. Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 129 (2006) 2266-2277
122. Sc in the same brain. Neurology 53 (1999) 2173-2176
123. Head M.W., Bunn T.J., Bishop M.T., McLoughlin V., Lowrie S., McKimmie C.S., Williams M.C., McCardle L., Mackenzie J., Knight R., Will R.G., and Ironside J.W. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: U.K. cases 1991-2002. Ann. Neurol. 55 (2004) 851-859
124. Sc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4 (2005) 805-814
125. Sc Profiling in Sporadic Creutzfeldt-Jakob Disease. PLoS. Med. 3 (2005) e14
126. Yull H.M., Ritchie D.L., Langeveld J.P., van Zijderveld F.G., Bruce M.E., Ironside J.W., and Head M.W. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am. J. Pathol. 168 (2006) 151-157
127. Head M.W., and Ironside J.W. Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein. Brain 129 (2006) 2238-2240
128. Demart S., Fournier J.G., Creminon C., Frobert Y., Lamoury F., Marce D., Lasmézas C., Dormont D., Grassi J., and Deslys J.P. New insight into abnormal prion protein using monoclonal antibodies. Biochem. Biophys. Res. Commun. 265 (1999) 652-657
129. Sc conformers induced by a synthetic peptide and several prion strains. J. Virol. 78 (2004) 2088-2099
130. Nazor K.E., Kuhn F., Seward T., Green M., Zwald D., Purro M., Schmid J., Biffiger K., Power A.M., Oesch B., Raeber A.J., and Telling G.C. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 24 (2005) 2472-2480
131. Wadsworth J.D., Asante E.A., Desbruslais M., Linehan J.M., Joiner S., Gowland I., Welch J., Stone L., Lloyd S.E., Hill A.F., Brandner S., and Collinge J. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306 (2004) 1793-1796
132. Asante E.A., Linehan J.M., Gowland I., Joiner S., Fox K., Cooper S., Osiguwa O., Gorry M., Welch J., Houghton R., Desbruslais M., Brandner S., Wadsworth J.D., and Collinge J. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10759-10764
133. C. J. Biol. Chem. 279 (2004) 28515-28521
134. Hill A.F., and Collinge J. Subclinical prion infection. Trends Microbiol. 11 (2003) 578-584
135. Tanaka M., Chien P., Yonekura K., and Weissman J.S. Mechanism of cross-species prion transmission an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121 (2005) 49-62
136. Bishop M.T., Hart P., Aitchison L., Baybutt H.N., Plinston C., Thomson V., Tuzi N.L., Head M.W., Ironside J.W., Will R.G., and Manson J.C. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 5 (2006) 393-398
137. Hill A.F., Zeidler M., Ironside J., and Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349 (1997) 99-100
138. Hill A.F., Butterworth R.J., Joiner S., Jackson G., Rossor M.N., Thomas D.J., Frosh A., Tolley N., Bell J.E., Spencer M., King A., Al-Sarraj S., Ironside J.W., Lantos P.L., and Collinge J. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353 (1999) 183-189
139. Glatzel M., Abela E., Maissen M., and Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349 (2003) 1812-1820
140. Hilton D.A., Sutak J., Smith M.E., Penney M., Conyers L., Edwards P., McCardle L., Ritchie D., Head M.W., Wiley C.A., and Ironside J.W. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J. Clin. Pathol. 57 (2004) 300-302
141. Head M.W., Ritchie D., Smith N., McLoughlin V., Nailon W., Samad S., Masson S., Bishop M., McCardle L., and Ironside J.W. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am. J. Pathol. 164 (2004) 143-153
142. Joiner S., Linehan J.M., Brandner S., Wadsworth J.D., and Collinge J. High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut 54 (2005) 1506-1508
143. Hilton D.A., Fathers E., Edwards P., Ironside J.W., and Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352 (1998) 703-704
144. Joiner S., Linehan J., Brandner S., Wadsworth J.D., and Collinge J. Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 73 (2002) 597-598
145. Wadsworth J.D., Joiner S., Fox K., Linehan J.M., Desbruslais M., Brandner S., Asante E.A., and Collinge J. Prion infectivity in vCJD rectum. Gut 56 (2007) 90-94
146. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., and Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol. Med. 7 (2001) 679-684
147. Jackson G.S., McKintosh E., Flechsig E., Prodromidou K., Hirsch P., Linehan J., Brandner S., Clarke A.R., Weissmann C., and Collinge J. An enzyme-detergent method for effective prion decontamination of surgical steel. J. Gen. Virol. 86 (2005) 869-878
148. Barbara J., and Flanagan P. Blood transfusion risk: protecting against the unknown. BMJ 316 (1998) 717-718
149. Bruce M.E., McConnell I., Will R.G., and Ironside J.W. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358 (2001) 208-209
150. Axon A.T., Beilenhoff U., Bramble M.G., Ghosh S., Kruse A., McDonnell G.E., Neumann C., Rey J.F., and Spencer K. Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy. Endoscopy 33 (2001) 1070-1080
151. Bramble M.G., and Ironside J.W. Creutzfeldt-Jakob disease: implications for gastroenterology. Gut 50 (2002) 888-890
152. Ghani A.C., Donnelly C.A., Ferguson N.M., and Anderson R.M. Updated projections of future vCJD deaths in the UK. BMC Infect. Dis. 3 (2003) 4
153. Barlow R.M., and Middleton D.J. Dietary transmission of bovine spongiform encephalopathy to mice. Vet. Rec. 126 (1990) 111-112
154. Wells G.A.H., Hawkins S.A.C., Green R.B., Austin A.R., Dexter I., Spencer Y.I., Chaplin M.J., Stack M.J., and Dawson M. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet. Rec. 142 (1998) 103-106
155. Hill A.F., Joiner S., Linehan J., Desbruslais M., Lantos P.L., and Collinge J. Species barrier independent prion replication in apparently resistant species. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10248-10253